ARCHIVES

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

This article is from The Cancer Letter archive.

Vol. 38 No. 02 | January 13, 2012

Download PDF Visit The Full Archive

Related Articles

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

CMS To Recognize NCCN’s Drug Compendium.

June 6, 2008

Program Announcements

July 25, 1986

CMS Inserts Unprecedented Conditions Into Medicare Coverage of Lung Screening

November 14, 2014

Stop Cancer Still Working To Raise Funds

March 22, 1991

DCE Board Approves Concepts For New Chemoprevention Groups, Retroviral Vaccine Research, Biochemical Markers, Feline Virus Studies

March 15, 1985